Mean periods in s of different actin-bound clutches for different substrate stiffnesses. by Kailas Shankar Honasoge (17108745)

Data Sheet 5_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.csv by Ben Wang (250897)

“…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”

Data Sheet 2_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.csv by Ben Wang (250897)

“…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”

Image 4_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.tif by Ben Wang (250897)

“…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”

Image 3_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.tif by Ben Wang (250897)

“…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”

Data Sheet 1_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.csv by Ben Wang (250897)

“…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”

Image 1_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.tif by Ben Wang (250897)

“…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”

Image 2_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.tif by Ben Wang (250897)

“…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”

Data Sheet 4_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.csv by Ben Wang (250897)

“…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”

Data Sheet 3_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.csv by Ben Wang (250897)

“…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”

Sequences within the RP23-350A20 BAC can mediate the BCR-induced decrease in transcription from the Ets1 promoter. by Alyssa Kearly (17425721)

Propofol treatment decreased ERK1/2 activation in A549 cells. by Jing Song (188926)

The ability of Bp4eA and Bp4eS to bind iron, to form redox active iron complexes and to cause an increase in the S phase and a decrease of G₂/M phase of cell cycle was n... by Eliska Potuckova (525220)

Loss of exostosin-1 (EXT1), specific reduction of heparan sulfate (HS) in fibroblasts, and decreased acidic mucosubstances in the stroma of <i>S100a4-Cre; Ext1</i>^<i>f/f</i> mice. by Ayumi Niwa (6256790)

Decreased radial growth of <i>A. fumigatus</i> isolate Af5517. by Nansalmaa Amarsaikhan (580405)

JHMV N1347A has decreased replication in the olfactory bulbs of mice. by Catherine M. Kerr (21492574)

Decreased radial growth of <i>A. fumigatus</i> isolate Af5517. by Nansalmaa Amarsaikhan (580405)

Relationship between mean SaFi at admission and clinical outcome at 60 days. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Therapeutic Targeting of Tumor Growth and Angiogenesis with a Novel Anti-S100A4 Monoclonal Antibody by Jose Luis Hernández (453962)

“…Conversely, when silencing S100A4 by shRNA technology, a dramatic decrease in tumor development of the pancreatic MiaPACA-2 cell line was observed. …”

Data Sheet 2_S100A4 targets PPP1CA/IL-17 to inhibit the senescence of sheep endometrial epithelial cells.pdf by Xiyao Jiao (18695935)

“…</p>Methods<p>The protein PPP1CA, which interacts with S100A4, was detected by immunoprecipitation-mass spectrometry of overexpression and knockdown of S100A4 and PPP1CA. …”